Announcements

Director Joel Ackerman of Champions Oncology, Inc. filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of options to purchase 31,216 shares of common stock on November 5, 2026.

Carl Russo, a director and 10% owner of Calix, Inc. (NYSE:CALX), filed a Form 4 on November 9, 2026, disclosing the sale of 75,000 shares of common stock on November 6, 2026, pursuant to a Rule 10b5-1 trading plan.

Director and 10% owner Scott R. Tobin filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of stock options to purchase common stock of Champions Oncology, Inc. (NASDAQ:CSBR), with the earliest transaction date of November 5, 2026.

Director Daniel Newman Mendelson filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of options to purchase common stock of Champions Oncology, Inc. (NASDAQ:CSBR), with the earliest transaction date of November 5, 2026.

Director Michelle T. Collins of Owens Corning filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 479 shares of common stock on November 6, 2026, as the share portion of her quarterly director retainer and fees.

Director Erin M. Stone filed a Form 4 with the SEC on November 9, 2026, disclosing a purchase of 500 shares of Security Midwest Bancorp, Inc. common stock on November 6, 2026.

Director David Sidransky filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of options to purchase 31,216 shares of Champions Oncology, Inc. common stock at an exercise price of $4.76 per share, with a transaction date of November 5, …